Biosimilar Delay

Negotiation Program Drug Selection for Initial Price Applicability Year 2028 (CMS-10844) - IRA

OMB: 0938-1443

IC ID: 271326

Information Collection (IC) Details

View Information Collection (IC)

Biosimilar Delay
 
No Modified
 
Required to Obtain or Retain Benefits
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Form and Instruction CMS-10844 Negotiation Program Drug Selection Information Collection Forms CMS-10844 Initial Price Applicability Year 2028_ Negotiation Program Drug Selection Information Collection Forms.docx Yes Yes Fillable Fileable

Health Health Care Services

 

10 0
   
Private Sector Businesses or other for-profits
 
   100 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 10 0 0 0 0 10
Annual IC Time Burden (Hours) 260 0 0 0 0 260
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
Track Change - Negotiation Program Drug Selection Information Collection Forms CMS-10844 Initial Price Applicability Year 2028 30-day Negotiation Program Drug Selection Information Collection Forms redline of proposed changes.pdf 09/30/2025
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2025 OMB.report | Privacy Policy